- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AZN
Recent news which mentions AZN
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
November 13, 2023
From InvestorPlace
Investigating AstraZeneca's Standing In Pharmaceuticals Industry Compared To Competitors
November 13, 2023
Tickers
AZN
From Benzinga
Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
November 10, 2023
From MarketWatch
From InvestorPlace
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
November 09, 2023
Tickers
AZN
From Motley Fool
AstraZeneca Joins Anti-Obesity Race Dominated By Eli Lilly And Novo Nordisk, Reports Mixed Q3 Earnings
November 09, 2023
Tickers
AZN
From Benzinga
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
November 09, 2023
From Benzinga
Virgin Galactic shares surge as space firm doubles revenue while Walt Disney stock jumps on spike in streaming customers
November 09, 2023
From MarketWatch
AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines
November 09, 2023
Tickers
AZN
From MarketWatch
The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman – and Martin Shkreli
November 06, 2023
From MarketWatch
7 Evergreen Stocks for Long-term Wealth Generation
November 03, 2023
From InvestorPlace
Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today?
November 01, 2023
From Benzinga
Why Is Cellectis (CLLS) Stock Up 175% Today?
November 01, 2023
From InvestorPlace
From InvestorPlace
Comparative Study: AstraZeneca And Industry Competitors In Pharmaceuticals Industry
October 30, 2023
Tickers
AZN
From Benzinga
3 No-Brainer Stocks to Buy for Under $100 Right Now
October 28, 2023
From Motley Fool
From MarketWatch
Stocks to own ahead of a rally that this $15 billion fund house says is coming soon
October 25, 2023
From MarketWatch
Why Is LumiraDx (LMDX) Stock Down 35% Today?
October 24, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
October 23, 2023
From Benzinga
Why Is LumiraDx (LMDX) Stock Up 323% Today?
October 23, 2023
From InvestorPlace
Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development
October 20, 2023
From Benzinga
United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 18, 2023
From Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
From Benzinga
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
October 16, 2023
From Benzinga
Understanding AstraZeneca's Position In Pharmaceuticals Industry Compared To Competitors
October 16, 2023
Tickers
AZN
From Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
From Benzinga
AstraZeneca's Tagrisso-Chemo Combo Under FDA Priority Review For Most Common Form Of Lung Cancer
October 16, 2023
Tickers
AZN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.